InnoPharmax Inc. (TPEX:4172)
Taiwan
· Delayed Price · Currency is TWD 14.45
-0.85 (-5.56%)
Mar 9, 2026, 2:09 PM CST
InnoPharmax Market Cap
InnoPharmax has a market cap or net worth of 1.55 billion as of March 9, 2026. Its market cap has decreased by -11.63% in one year.
Market Cap
1.55B
Enterprise Value
1.33B
Revenue
55.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.45
Market Cap Chart
Since September 13, 2012, InnoPharmax's market cap has increased from 1.54B to 1.55B, an increase of 0.83%. That is a compound annual growth rate of 0.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tien Liang BioTech | 1.65B |
| GeneFerm Biotechnology | 1.72B |
| Winston Medical Supply | 1.48B |
| TSH Biopharm Corporation | 2.00B |
| DV Biomed | 1.34B |
| Excelsior Biopharma | 1.26B |
| Golden Biotechnology | 2.26B |
| Anxo Pharmaceutical | 1.13B |